Cartilage-binding antibodies induce pain through immune complex–mediated activation of neurons
Male
570
610
Mice, Transgenic
Antigen-Antibody Complex
Cartilage Oligomeric Matrix Protein
Arthritis, Rheumatoid
Mice
03 medical and health sciences
Immunology in the Medical Area (including Cell and Immunotherapy)
Animals
Tissues and Organs (q-bio.TO)
Collagen Type II
Research Articles
Autoantibodies
Neurons
Mice, Inbred BALB C
0303 health sciences
Behavior, Animal
Receptors, IgG
Klinisk medicin
Neurosciences
Immunology in the medical area
Antibodies, Monoclonal
Quantitative Biology - Tissues and Organs
Arthralgia
3. Good health
Mice, Inbred C57BL
Disease Models, Animal
Cartilage
Immunologi inom det medicinska området
Quantitative Biology - Neurons and Cognition
FOS: Biological sciences
Mice, Inbred CBA
Female
Neurons and Cognition (q-bio.NC)
Clinical Medicine
DOI:
10.1084/jem.20181657
Publication Date:
2019-06-13T18:45:16Z
AUTHORS (31)
ABSTRACT
Rheumatoid arthritis–associated joint pain is frequently observed independent of disease activity, suggesting unidentified pain mechanisms. We demonstrate that antibodies binding to cartilage, specific for collagen type II (CII) or cartilage oligomeric matrix protein (COMP), elicit mechanical hypersensitivity in mice, uncoupled from visual, histological and molecular indications of inflammation. Cartilage antibody–induced pain-like behavior does not depend on complement activation or joint inflammation, but instead on tissue antigen recognition and local immune complex (IC) formation. smFISH and IHC suggest that neuronal Fcgr1 and Fcgr2b mRNA are transported to peripheral ends of primary afferents. CII-ICs directly activate cultured WT but not FcRγ chain–deficient DRG neurons. In line with this observation, CII-IC does not induce mechanical hypersensitivity in FcRγ chain–deficient mice. Furthermore, injection of CII antibodies does not generate pain-like behavior in FcRγ chain–deficient mice or mice lacking activating FcγRs in neurons. In summary, this study defines functional coupling between autoantibodies and pain transmission that may facilitate the development of new disease-relevant pain therapeutics.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (58)
CITATIONS (80)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....